Evolution of the Average Target: Lineage, Inc.

Evolution of the Average Target - Lineage, Inc.

Evolution of the Target Price: Lineage, Inc.

Evolution of the Target Price - Lineage, Inc.

Changes in Analyst Recommendations: Lineage, Inc.

bb47f4c845e848af5bc45395.d4UxyuDSbAPGZwMXwpvfbt6WdjfWp3mN7t2pGs37Uxs.Ev99vLGDXjKkVnovktqIBKv9EG2M9R7G35P8cvy0Pno953i8k-QBSpEsMw~3146e450a7674628bf9bac8098e4b0d9
09-09 Morgan Stanley Upgrades Lineage to Overweight From Equalweight MT
09-09 Analyst recommendations: Westlake, American Airlines, Block, Lineage, Workday… Zonebourse
08-17 Lineage Seen Benefiting From Improving Industry Conditions, RBC Capital Markets Says MT
08-17 RBC Raises Price Target on Lineage to $48 From $44, Keeps Outperform Rating MT
07-29 Mizuho Securities Upgrades Lineage to Outperform From Neutral, Raises Price Target to $47 From $40 MT
07-21 Analyst recommendations: Gilead, Salesforce, Goldman Sachs, Carvana, Crowdstrike… Zonebourse
07-17 UBS Raises Price Target on Lineage to $45 From $35, Maintains Neutral Rating MT
06-17 Truist Adjusts Price Target on Lineage to $46 From $44, Maintains Buy Rating MT
06-02 Lineage Shows Early Recovery Signs as Demand Stabilizes, Morgan Stanley Says MT
06-02 Morgan Stanley Raises Price Target on Lineage to $47 From $39, Keeps Equalweight Rating MT
06-02 Analyst recommendations: Caesars Entertainment, Intuit, Caterpillar, Dell… Zonebourse
03-04 Truist Raises Price Target on Lineage to $44 From $41, Keeps Buy Rating MT
03-02 RBC Raises Price Target on Lineage to $44 From $42, Keeps Outperform Rating MT
01-20 Truist Raises Price Target on Lineage to $41 From $40, Keeps Buy Rating MT
01-13 Lineage Shares Fall After Barclays Downgrade MT
01-13 Barclays Downgrades Lineage to Equalweight From Overweight, Lowers Price Target to $38 From $47 MT
01-08 UBS Adjusts Lineage Price Target to $35 From $41, Maintains Neutral Rating MT
12-23 Truist Cuts Price Target on Lineage to $40 From $53, Keeps Buy Rating MT
12-18 Baird Downgrades Lineage to Neutral From Outperform, Adjusts PT to $39 From $45 MT
12-18 Analyst recommendations: American Express, Merck, Rivian, Albemarle, Micron… Zonebourse
11-12 RBC Lowers Price Target on Lineage to $45 From $51, Keeps Outperform Rating MT
11-10 Lineage Insider Bought Shares Worth $345,630, According to a Recent SEC Filing MT
11-06 Piper Sandler Downgrades Lineage to Neutral From Overweight, Adjusts Price Target to $41 From $55 MT
25-10-14 UBS Adjusts Price Target on Lineage to $41 From $45, Maintains Neutral Rating MT
25-08-22 Truist Cuts Price Target on Lineage to $53 From $60, Keeps Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+29.84%
+11%
+25.04%
+16.61%
+26.89%
+10.29%
+17.47%
+15.05%
+27.99%
+12.1%
Average +19.23%
Weighted average by Cap. +17.45%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
33.28USD
Average target price
43.21USD
Spread / Average Target
+29.84%
High Price Target
55.00USD
Spread / Highest target
+65.26%
Low Price Target
35.00USD
Spread / Lowest Target
+5.17%

Analyst Consensus Detail

Analyst consensus - Lineage, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Lineage, Inc.
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Lineage, Inc.
  1. Stock Market
  2. Stocks
  3. LINE Stock
  4. Consensus Lineage, Inc.